IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Sold by Mn Services Vermogensbeheer B.V.

Mn Services Vermogensbeheer B.V. trimmed its position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 0.6% during the third quarter, Holdings Channel.com reports. The firm owned 32,460 shares of the company’s stock after selling 200 shares during the period. Mn Services Vermogensbeheer B.V.’s holdings in IDEXX Laboratories were worth $16,399,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of IDXX. Crewe Advisors LLC acquired a new position in IDEXX Laboratories in the first quarter valued at $26,000. Ridgewood Investments LLC acquired a new position in IDEXX Laboratories in the 2nd quarter worth $27,000. Institutional & Family Asset Management LLC acquired a new position in IDEXX Laboratories in the 2nd quarter worth $28,000. E Fund Management Hong Kong Co. Ltd. grew its stake in shares of IDEXX Laboratories by 5,700.0% during the third quarter. E Fund Management Hong Kong Co. Ltd. now owns 58 shares of the company’s stock valued at $29,000 after acquiring an additional 57 shares in the last quarter. Finally, Mowery & Schoenfeld Wealth Management LLC grew its stake in IDEXX Laboratories by 750.0% during the 3rd quarter. Mowery & Schoenfeld Wealth Management LLC now owns 68 shares of the company’s stock valued at $34,000 after purchasing an additional 60 shares in the last quarter. 87.84% of the stock is currently owned by hedge funds and other institutional investors.

IDEXX Laboratories Trading Down 0.7 %

Shares of IDXX stock opened at $414.52 on Tuesday. IDEXX Laboratories, Inc. has a 1 year low of $404.74 and a 1 year high of $583.39. The firm has a market capitalization of $34.12 billion, a PE ratio of 39.97, a price-to-earnings-growth ratio of 3.64 and a beta of 1.36. The stock has a fifty day moving average of $477.37 and a two-hundred day moving average of $486.74. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.03 and a current ratio of 1.42.

IDEXX Laboratories (NASDAQ:IDXX) last posted its quarterly earnings data on Thursday, October 31st. The company reported $2.80 earnings per share for the quarter, topping the consensus estimate of $2.69 by $0.11. The business had revenue of $975.50 million during the quarter, compared to the consensus estimate of $980.32 million. IDEXX Laboratories had a net margin of 22.53% and a return on equity of 55.42%. The company’s quarterly revenue was up 6.6% compared to the same quarter last year. During the same quarter in the prior year, the company posted $2.53 earnings per share. As a group, research analysts expect that IDEXX Laboratories, Inc. will post 10.45 EPS for the current year.

Analyst Upgrades and Downgrades

A number of research firms have commented on IDXX. JPMorgan Chase & Co. reduced their price objective on shares of IDEXX Laboratories from $630.00 to $575.00 and set an “overweight” rating on the stock in a research note on Friday, October 11th. Barclays reduced their price target on shares of IDEXX Laboratories from $570.00 to $481.00 and set an “overweight” rating on the stock in a research report on Monday. BTIG Research initiated coverage on IDEXX Laboratories in a report on Thursday, July 25th. They issued a “buy” rating and a $580.00 price objective for the company. Piper Sandler reaffirmed a “neutral” rating and set a $435.00 target price (down previously from $520.00) on shares of IDEXX Laboratories in a report on Monday. Finally, StockNews.com lowered IDEXX Laboratories from a “buy” rating to a “hold” rating in a research report on Wednesday, July 10th. Three equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $552.38.

IDEXX Laboratories Company Profile

IDEXX Laboratories, Inc develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy.